Search - tctmd.com

Displaying 561 - 580 of 648

Sort: Relevancy | Date

Presentation TCT 2015

Creating a New Paradigm for Pulmonary Embolism Intervention (Inari Medical)

Presenter: Brian Cox

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

Presentation Aortovascular 2015

The Emergence of Pulmonary Embolism Response Teams (PERT)

Presenter: William A. Gray

September 18, 2015

Presentation Aortovascular 2015

An Algorithmic Management Strategy for Pulmonary Embolism

Presenter: Erika S. Berman-Rosenzweig

September 18, 2015

Presentation Aortovascular 2015

Acute Pulmonary Embolism: Diagnosis and risk stratification

Presenter: Philip Green

September 18, 2015

News Daily News

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

Todd Neale

September 10, 2015

News Daily News

A los Pacientes Con Embolismos Pulmonares Agudos les Va Mejor con Trombolisis Más Dirigida

Todd Neale

September 10, 2015

Presentation

Systemic vs Catheter-Directed Thrombolysis in Pulmonary Embolism

Presenter: N Patel

September 04, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

Advertisement

Creating a New Paradigm for Pulmonary Embolism Intervention (Inari Medical)

Companies With Innovative Technologies Compete in TCT Shark Tank

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

Use of LAA Occlusion in Low-Risk Patients Debated

The Emergence of Pulmonary Embolism Response Teams (PERT)

An Algorithmic Management Strategy for Pulmonary Embolism

Acute Pulmonary Embolism: Diagnosis and risk stratification

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

A los Pacientes Con Embolismos Pulmonares Agudos les Va Mejor con Trombolisis Más Dirigida

Systemic vs Catheter-Directed Thrombolysis in Pulmonary Embolism

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

肺栓塞发作后，二级抗凝效果未持续

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content